期刊文献+

自发性高血压大鼠心血管组织中肾上腺髓质素2受体系统的变化 被引量:2

Variation of receptors of ADM2 in cardiovascular tissue in spontaneously hypertensive rat
原文传递
导出
摘要 目的:探讨自发性高血压大鼠(SHR)心血管组织中肾上腺髓质素2(ADM2)及其受体系统的基因表达和蛋白水平变化,以及与ADM2血浆水平的相互关系。方法:8只11周龄的雄性SHR(SHR组),8只同龄的雄性Wistar Kyoto大鼠(WKY组)。半定量RT-PCR方法测定大鼠心血管组织中ADM2及其受体系统降钙素受体样受体(CRLR)和受体活性修饰蛋白(RAMPs)mRNA水平;Western blot法测定心血管组织中CRLR和RAMPs的蛋白含量;放射免疫法测定血浆中ADM2含量。结果:①SHR心肌中ADM2、CRLR、RAMP1、RAMP2和RAMP3的mRNA水平较WKY组分别高76.1%、41.6%、69.2%、48.3%和109.1%(均P<0.05);主动脉中分别高171.11%(P<0.01)、69.9%(P<0.05)、100.09%(P<0.01)、131.8%和69.7%(均P<0.05)。②SHR心肌中CRLR、RAMP1和RAMP3的蛋白水平较WKY组分别高136.0%、60.3%、63.9%(均P<0.05),而RAMP2则显著增高292.5%(P<0.01);SHR主动脉中CRLR、RAMP1、RAMP2和RAMP3的蛋白水平较WKY组分别高112.4%、92.3%、41.1%和67.7%(均P<0.01)。③SHR的ADM2血浆含量和受体的蛋白水平-CRLR、RAMP1、RAMP2在主动脉中的含量呈显著正相关(r=0.8838,0.9299,0.8881,均P<0.05)。结论:ADM2及其受体系统在原发性高血压的发生发展过程中可能具有重要的病理生理意义。 Objective : To compare the difference of adrenomedullin 2 ( ADM 2 ) and its receptor in its genetic expression and protein content in cardiovascular tissue between SHRs and Wistar Kyoto(WKY) rats. And the relationship of the content of ADM2 in plasma with its recipient system in protein level is discussed as well. Method: 8 male, 11-week- old SHRs were chosen as experiment group, other 8 male WKY rats at the same age were set as control group. The mRNA expression of ADM2 and its receptor were measured by RT-PCR method. Protein levels of CRLR and RAMPs were measured by Western blot. The content of ADM2 in plasma was determined by radioimmunoassay analysis. Result:①The mRNA levels of ADM2, CRLR, RAMP1, RAMP2 and RAMP3 were elevated by 76. 11%, 41.6%, 69. 2%, 48.3% and 109.1% (P〈0. 05) respectively in myocardia and by 171.11%, 69.9%, 100.09%, 131.8% and 69. 7%(P〈0. 05) in aortas. ②The protein content of CRLR, RAMP1, RAMP2 and RAMP3 were increased by 136. 0%(P〈0. 05), 60.3%(P〈0.05), 63. 9%(P〈0. 05), 292.5%(P〈0.01) in myocardia and by 112.4%, 92.3%, 41.1% and 67.7%(P〈0.01) in aortas.③The elevated protein content of CRLR, RAMP1 and RAMP2 in aortas were positively correlatedelated with that of protein levels of its recipient system(r=0. 883 8,0. 929 9,0. 888 1 ,P〈0.05). Conelusion:AMD2 and its receptor system may play an important role in the pathogenesis and development of essential hypertension.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2008年第7期532-536,共5页 Journal of Clinical Cardiology
基金 国家自然科学基金(No:30570738) 北京市自然科学基金(No:7052041)
关键词 肾上腺髓质素2 自发性高血压大鼠 降钙素受体样受体 受体活性修饰蛋白 Adrenomedullin2 Spontaneously Hypertensive Rat Calcitonin receptor-like receptor Receptoractivity modifying proteins
  • 相关文献

参考文献10

  • 1ROH J, CHANG C L, BHALLA A, et al. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes [J]. J Biol Chem, 2003, 279:7264-7274.
  • 2TAKEI Y, INOUE K, OGOSHI M, et al. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator[J]. FEBS Lett, 2004, 556: 53-58.
  • 3AMARA S G, JONAS V, ROSENFELD M G, et al. Alternative RNA processing in calcitonin gene expression gene rates mRNAs encoding different polypeptide products[J]. Nature, 1982,298 : 240-244.
  • 4KOBAYASHI H, YAMAMOTO R, KITAMURA K, et al. Cyclic AMP-dependent synthesis and release of adrenomedullin and proadrenomedullin N-terminal 20 peptide in cultured bovine adrenal chromaffin cells[J]. EurJ Biochem, 1999, 263: 702-708.
  • 5奥斯伯F,布伦特R,金斯顿RE,等.精编分子生物学实验指南[M].第4版,科学出版社,1998:651-691.
  • 6萨母布鲁克J,费里奇EF,曼民阿蒂斯T.《分子克隆》实验指南[M].第2版,北京:科学出版社,1996:407-416.
  • 7KITAMURA K, KATO J, KAWAMOTO M, et al. The intermidiate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma [J]. Biochem Biophys Res Commun, 1998, 244:551-555.
  • 8齐永芬,唐朝枢.降钙素基因相关肽家族的受体活性修饰蛋白[J].生理科学进展,2001,32(3):251-253. 被引量:11
  • 9MCLATCHIE L M, FRASER N J, MAIN M J, et al. RAMPs regulate the transport and ligand specifity of the calcitonin-receptor-liker receptor [J]. Nature, 1998, 393:3332-3339.
  • 10ZHAO Y Y, DAVID B, LISA R S,et al. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor systerm following blood pressure reduction in nitric oxide-deficient hypertension[J]. J Pharmacol Exp Ther, 2006, 316: 1269-1281.

二级参考文献10

  • 1[1]Martinez A, Kapas S, Miller MJ, et al. Coexpression of receptors for adrenomedullin,calcitonin gene-related peptide,and amylin in pancreatic beta cells. Endocrinology, 2000, 141∶406~411.
  • 2[2]Wimalawansa SJ. Amylin,calcitonin gene-related peptide,calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol, 1997,11∶167~239.
  • 3[3]Mclatchie LM, Fraser NJ, Main MJ, et al.RAMPs regulate the transport and ligand specifity of the calcitonin -receptor-like receptor. Nature, 1998,393∶333~339.
  • 4[4]Frayon S, Cueille C,Gnidehou S, et al. Dexamethasone increases RAMP1 and CRLR mRNA expression in human vascular smooth muscle cells. Biochem Biophys Res Commun, 2000,270∶1063~1067.
  • 5[5]Nagac T, Mukoyama M, Sugawara A, et al. Rat receptor-activity-modifying protein(RAMPs) for adrenomedullin/CGRP receptor: cloning and regulation in obstructive nephropathy. Biochem Biophys Res Commun, 2000,270∶89~93.
  • 6[6]Foord SM,Marshall FH. RAMPs: accessory proteins for seven transmembrane domain receptors.Trends Pharmacol Sci, 1999,20∶184~187.
  • 7[7]Christopoulos G, Peery KJ, Morfis M, et al. Multiple amylin receptors arise from receptor activity modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol, 1999,56∶235~242.
  • 8[8]Frash NJ, Wise A, Brown J, et al. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Mol Parmacol, 1999,55∶1054~1059.
  • 9[9]Zumpe ET, Tilakaratne N, Fraser NJ, et al. Multiple ramp domain are required for generation of amylin receptor phenotype from the calcitonin receptor gene product. Biochem Biophys Res Commun, 2000,267:368~372.
  • 10[10]Oie E, Vinge LE, Yndestad A, et al. Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation, 2000, 101∶415~422.

共引文献10

同被引文献59

  • 1罗碧辉,曾昭华,易家骥,何兆初,汪新良,潘洁贞,苏诚坚.培哚普利对盐敏感性高血压大鼠心脏形态及其功能的影响[J].中国心血管杂志,2004,9(6):393-396. 被引量:7
  • 2韩运峰,苏诚坚,区碧如.非洛地平缓释片及缬沙坦对感觉神经损伤性盐敏感性高血压大鼠的降压作用及其机制探讨[J].中华心血管病杂志,2005,33(3):255-259. 被引量:13
  • 3杨靖辉,贾月霞,任永生,唐朝枢.中叶素1-53对大鼠动脉血压的影响及其作用机制[J].高血压杂志,2005,13(11):711-715. 被引量:11
  • 4CLAPHAM D E. TRP channels as cellular sensors [J]. Nature, 2003, 426: 517--524.
  • 5WATANABE H, MURAKAMI M, OHBA T, et al. TRP channel and cardiovascular disease [J]. Pharmacol Ther, 2008, 118: 337--351.
  • 6LI D, PENG J, XIN H Y, et al. Calcitonin gene-related peptide-mediated antihypertensive and anti- platelet effects by rutaecarpine in spontaneously hypertensive rats [J]. Peptides, 2008, 29: 1781- 1788.
  • 7DENG P Y, LI Y J. Calcitonin gene-related peptide and hypertension [J]. Peptides, 2005, 26: 1676- 1685.
  • 8WATSON R E, SUPOWIT S C, ZHAO H, et al. Role of sensory nervous system vasoactive peptides in hypertension [J]. Braz J Med Biol Res, 2002, 35: 1033--1045.
  • 9BELL D, MCDERMOTT B J. Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems [J]. Br J Pharmacol, 2008, 153..247--262.
  • 10KISSIN I. Vanilloid-induced conduction analgesia: selective, dose-dependent, long-lasting, with a low level of potential neurotoxicity[J]. Anesth Analg, 2008, 107: 271--281.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部